{
    "organizations": [],
    "uuid": "19fbbd2b8598c1026e5c8e18b0e83028cbd15a3a",
    "author": "",
    "url": "https://www.reuters.com/article/brief-prokaryotics-announces-licensing-a/brief-prokaryotics-announces-licensing-agreement-with-merck-for-novel-investigational-antibiotic-candidates-idUSFWN1PK1A4",
    "ord_in_thread": 0,
    "title": "BRIEF-Prokaryotics Announces Licensing Agreement With Merck For Novel Investigational Antibiotic Candidates",
    "locations": [],
    "highlightText": "",
    "language": "english",
    "persons": [],
    "text": " 46 PM / Updated 12 minutes ago BRIEF-Prokaryotics Announces Licensing Agreement With Merck For Novel Investigational Antibiotic Candidates Reuters Staff \nJan 25 (Reuters) - Merck & Co Inc: \n* PROKARYOTICS ANNOUNCES LICENSING AGREEMENT WITH MERCK FOR NOVEL INVESTIGATIONAL ANTIBIOTIC CANDIDATES \n* PROKARYOTICS - ANNOUNCES LICENSING AGREEMENT WITH MERCK FOR NOVEL INVESTIGATIONAL ANTIBIOTIC CANDIDATES \n* PROKARYOTICS - CO GAINS WORLDWIDE RIGHTS TO DEVELOP EARLY PRE-CLINICAL PROGRAMS FOR GRAM-NEGATIVE, GRAM-POSITIVE BACTERIAL CELL ENVELOPE ENZYMES \n* PROKARYOTICS - SPECIFIC TERMS OF AGREEMENT WERE NOT DISCLOSED Source text for Eikon: Further company coverage:",
    "published": "2018-01-25T15:46:00.000+02:00",
    "crawled": "2018-01-25T16:04:40.009+02:00",
    "highlightTitle": "",
    "preprocessed_text": [
        "pm",
        "updated",
        "minute",
        "ago",
        "announces",
        "licensing",
        "agreement",
        "merck",
        "novel",
        "investigational",
        "antibiotic",
        "candidate",
        "reuters",
        "staff",
        "jan",
        "reuters",
        "merck",
        "co",
        "inc",
        "prokaryotics",
        "announces",
        "licensing",
        "agreement",
        "merck",
        "novel",
        "investigational",
        "antibiotic",
        "candidate",
        "prokaryotics",
        "announces",
        "licensing",
        "agreement",
        "merck",
        "novel",
        "investigational",
        "antibiotic",
        "candidate",
        "prokaryotics",
        "co",
        "gain",
        "worldwide",
        "right",
        "develop",
        "early",
        "program",
        "bacterial",
        "cell",
        "envelope",
        "enzyme",
        "prokaryotics",
        "specific",
        "term",
        "agreement",
        "disclosed",
        "source",
        "text",
        "eikon",
        "company",
        "coverage"
    ]
}